Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates (Q36372263)

13 August 2017

1 reference

title

Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates (English)

1 reference

13 August 2017

Lorne J Brandes

1

1 reference

PubMed ID

16422394

13 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Critical Reviews in Toxicology

13 August 2017

1 reference

13 August 2017

35

1 reference

13 August 2017

587-592

1 reference

13 August 2017

6

1 reference

"Hormesis"--an inappropriate extrapolation from the specific to the universal

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Hormesis - a pharmaceutical industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Underestimation of chronic toxicities of food additives and chemicals: the bias of a phantom rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Hormesis: a revolution in toxicology, risk assessment and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Tamoxifen-induced hypercalcemia in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

The effects of tricyclic antidepressants on breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Antidepressant medication use and breast cancer risk: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Male breast neoplasia in association with selective serotonin re-uptake inhibitor therapy: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Enhancement of tumor growth by drugs with some common molecular actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Displacement of histamine from liver cells and cell components by ligands for cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Cytochromes P450 mediating the N-demethylation of amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Phase III evaluation of fluoxetine for treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

Antidepressant Medications and Risk for Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440500246801

10.1080/10408440500246801

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16422394